Work

Bortezomib With or Without Irinotecan in Relapsed or Refractory Colorectal Cancer: Results From a Randomized Phase II Study

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.14.0152

Authors: Peter S. Kozuch, Caio Max Rocha-Lima, Tomislav Dragovich, Howard Hochster, Bert H. O'Neil, Omar T. Atiq, J. Marc Pipas, David P. Ryan, Heinz-Josef Lenz

Institutions: University of North Carolina at Chapel Hill, Dartmouth–Hitchcock Medical Center, St. Luke's-Roosevelt Hospital Center, University of Miami, Massachusetts General Hospital, Sylvester Comprehensive Cancer Center, New York University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2025839879

FWCI: 2.09

Cites: 57

Cited by: 43

Related to: 10